Introduction {#S0001}
============

Advances in nanotechnology and molecular biochemistry, the ability to decrypt and elaborate multiple artificial materials, the continuous search for new targets, and the disentangling of diverse signaling pathways of many medical disorders have had a conspicuous influence on modern medical practices.[@CIT0001]--[@CIT0004] Among the various nanomaterials designed for biomedical applications, two-dimensional (2D) materials, especially transition metal dichalcogenides (eg, MoS~2~, WS~2~, TiS~2~, MoSe~2~, and WSe~2~)[@CIT0005] and transition metal oxides (TMOs, eg, MnO~2~),[@CIT0006] have received a substantial amount of recent attention due to their distinct structure--property relationships in multiple fields, eg, optoelectronics, spintronics, catalysis, defect engineering, and energy-related applications.[@CIT0007]--[@CIT0009] Among these materials, manganese oxides have attracted increasing attention because Mn is the twelfth most common element on the planet and the third most abundant transition element after iron and titanium.[@CIT0010] Manganese (II) ions function as cofactors in a number of enzymes with varying functionalities as well as being key components in the oxygen-evolving complexes of photosynthetic plants.[@CIT0011] Additionally, manganese oxide (Mn-oxide) has a variety of structures (nanorods, nanobelts, nanosheets (NSs), nanowires, nanotubes, nanofibers and so on)[@CIT0012] and compositions (MnO, Mn~5~O~8~, Mn~2~O~3~, MnO~2~, and Mn~3~O~4~)[@CIT0013] which further broadens its applications in a diverse range of fields. Hoseinpour et al reviewed the structures, sizes and applications of Mn NPs prepared via different green synthetic methods in detail.[@CIT0014] Among the various nanostructures, NS is two-dimensional nanostructure with thickness ranging from 1 to 100 nm. A typical NS example is graphene, which is composed of a single layer of carbon atoms with hexagonal lattice.[@CIT0015] NS shares several similar common features, eg, ultralarge specific surface areas and high surface-to-volume ratios, allowing easy contact between reactant molecules and the active sites, thus providing enhanced catalytic activities[@CIT0016] as well as unique optical properties (described below) and excellent photothermal therapy (PTT), etc.[@CIT0017] MnO~2~ nanosheets (MnO~2~ NSs) are composed of MnO~6~ octahedra that share edges, with manganese ions occupying the centers of the octahedra and being coordinated to the six nearest oxygen ions, while each oxygen ion is coordinated to the three nearest manganese ions.[@CIT0018],[@CIT0019] Similar to the structures of other 2D materials, MnO~2~ NSs possess high specific surface areas and a thickness of nanometers to micrometers. Moreover, the redox reactions between MnO~2~ and glutathione (GSH) in acidic environment have favored their applications in activatable fluorescent biosensors, controlled drug delivery and activable T~1~-MR imaging.[@CIT0020]--[@CIT0022] As a class of novel and facilely synthesized 2D TMOs with good biocompatibility, MnO~2~ NSs have received increased attention across a vast range of disciplines, especially biomedicine. In this review, we aim to provide an overview of the state-of-the-art syntheses, biomedical applications, toxicological assessments and challenges/opportunities in the research field of MnO~2~ NSs. First, various synthetic strategies for the preparation of MnO~2~ NSs are introduced. Then, we briefly discuss their main biomedical applications. Furthermore, the in vitro and in vivo toxicological evaluations are highlighted. Ultimately, we provide some personal perspectives on the future directions of this promising research field.

Synthesis of manganese dioxide nanosheets (MnO~2~ NSs) {#S0002}
======================================================

As a class of 2D nanomaterials, NSs are characterized by their nanometer thicknesses as well as lateral dimensions ranging from the submicrometers to micrometer scales. MnO~2~ NSs with extremely large surface-area-to-mass ratios (SMRs) display a number of distinctive physicochemical properties compared with their bulk form. Hence, the synthesis of MnO~2~ NSs is of great significance for a variety of novel biomedical applications. To date, several methods have been developed for the preparation of MnO~2~ NSs. In general, these methods can be classified into two categories: top-down and bottom-up approaches, as is also true of other types of 2D nanomaterials.[@CIT0023] In 2003, Omomo et al. first reported the formation and characterization of unilamellar 2D crystallites of MnO~2~ as well as the swelling and exfoliation behavior of layered manganese oxide, H~0.13~MnO~2~·H~2~O, which was dissolved in tetrabutylammonium hydroxide solution.[@CIT0024] This traditional top-down approach always utilizes ion-exchange and exfoliation of bulk MnO~2~ templates to obtain MnO~2~ NSs. However, this route entails a cost-demanding and time-consuming multistep high-temperature solid-state synthetic process. Moreover, one hurdle that the obtained NSs possess a wide thickness distribution, which is a challenge that must be overcome before their possible future application. In 2008, Kazuya Kai et al demonstrated a single-step bottom-up approach to directly synthesize MnO~2~ NSs for the first time,[@CIT0025] drawing from the synthetic methodology for producing Ti~1-δ~O~2~monosheets with uniform shapes and sizes reported by Yoon and coworkers.[@CIT0026] Since then, the bottom-up strategy, as a novel approach to synthesize MnO~2~ NSs, has attracted the attention of most researchers in this field, owing to its significant advantages, such as an easier preparation and better controlled exfoliation and reaction steps. In this review, we focus on the bottom-up methods for obtaining MnO~2~ NSs, and their sizes and morphologies when prepared by different approaches have been summarized in [Table 1](#T0001){ref-type="table"}.Table 1Summarized sizes and morphologies of MnO~2~ NSs synthesized by different approachesMethodReaction materialsMorphologyLateral dimensionsThicknessReferenceTop-DownH~0.13~MnO~2~·0.7H~2~O + TBAOHNanosheet structure\<50 nm0.91±0.07nm[@CIT0024]Bottom-Up (reductive)KMnO~4~+ MESNanosheet structure141 nm\~1.5 nm[@CIT0028]Bottom-Up (reductive)KMnO~4~+ SDSSingle-layered nanosheet\~200 nm0.77--0.95 nm[@CIT0029]Bottom-Up (oxidative)MnCl~2~+ EDTA + NaOHThin film of nanosheet2--5 µm width\~10 nm[@CIT0027]Bottom-Up (oxidative)MnCl~2~+ TMA^.^OHSingle-layered NS\<200 nmNearly 80% \<1 nm[@CIT0025]Bottom-Up (oxidative)MnCl~2~+ H~2~O~2~+ TMA^.^OHA two-dimensional\
sheet structure\~200 nm\~1.3 nm.[@CIT0111]Bottom-Up (oxidative)MnCl~2~+ (NH~4~)~2~S~2~O~8~+ TMA.OHFlat morphology2 µm\~4.07 nm[@CIT0035]Bottom-Up (oxidative)MnCl~2~+ H~2~O~2~+ TMA.OHA sheet-like structureN/A\~1.5 nm[@CIT0036]Bottom-Up (oxidative)MnCl~2~+ H~2~O~2~+ TMA^.^OHNanosheet structure100--200 nmN/A[@CIT0069]Bottom-Up (oxidative)MnCl~2~+ H~2~O~2~+ TMA^.^OHPolycrystalline sheet structure141 nm1.5 nm[@CIT0150]Bottom-Up (oxidative)MnCl~2~+ H~2~O~2~+ TMA^.^OHSingle-layer sheet structure200 nm\~1.5 nm[@CIT0170][^2]

Manganese ion (Mn^2+^) based oxidative methodology {#S0002-S2001}
--------------------------------------------------

The preparation of multilayer MnO~2~ NSs (ca. 10 nm in thickness) with bottom-up approaches has mainly been achieved by the oxidation of Mn^2+^ or the reduction of KMnO~4~ with a self-sacrificing template (eg, graphene oxide nanosheets; GO NSs) or a chelating agent (eg, EDTA)[@CIT0027] in the presence of reducing or oxidizing reagents. In 2007, Oaki and Imai proposed bottom-up approach to obtain MnO~2~ NSs by the oxidation of manganese ions with dissolved oxygen in the solution.[@CIT0027] EDTA was utilized as a chelating agent for the manganese ions (Mn^2+^) to hinder the rapid precipitation of Mn(OH)~2~. However, their precipitate consisted of multiple layers with thicknesses of 10 nanometers or greater (ie, over 10 layers). Moreover, the time-consuming process (at least 3 days) was unavoidable. To address these issues, inspired by the single-step route reported by Yoon for the synthesis of titanate dioxide nanosheets (Ti~1-δ~O~2~ NSs), Kazuya Kai and coworkers attempted to prepare MnO~2~ NSs with hydrogen peroxide (H~2~O~2~) as an oxidant in an alkaline medium and TMA cations for the exfoliation of layered H/MnO~2~. However, unlike the method form Yoon, their reaction readily proceeded at ambient temperature instead of heating under reflux ([Figure 1](#F0001){ref-type="fig"}).[@CIT0026] Figure 1Schematic illustration of the single-step oxidative method with H~2~O~2~ at room temperature versus the conventional method.**Note:** Reprinted with permission from Kai K, Yoshida Y, Kageyama H, et al. Room-temperature synthesis of manganese oxide monosheets. *J Am Chem Soc*. 2008;130(47):15938--15943.[@CIT0025] Copyright (2008) American Chemical Society.

Potassium permanganate (PP, KMnO~4~)-based reductive methodology {#S0002-S2002}
----------------------------------------------------------------

Compared to the top-down and the oxidative bottom-up methods, a reductive bottom-up method has been developed in recent years. With KMnO~4~ as the Mn source, different reactive agents have been introduced to prepare MnO~2~ NSs. For example, Liu et al first obtained MnO~2~ NSs via the addition of an aqueous KMnO~4~ solution into a 2-(N-morpholino)ethanesulfonic acid (MES) buffer at pH 6. Compared with other reducing reagents (eg, MnCl~2~ and ethanol), the use of the MES buffer as the reducing agent showed the best results ([Figure 2A](#F0002){ref-type="fig"}).[@CIT0028] Later, in 2015, Yin and coworkers developed a facile template-free, one-step and one-phase reductive strategy to synthesize single-layered MnO~2~ NSs with sodium dodecylsulfate (SDS) as the reducing agent. In their system, SDS not only played the role of a precursor of dodecanol to reduce KMnO~4~ but also was a structure-directing agent to promote the formation of the MnO~2~ monosheets, which opened up the possibility of constructing other NS without the use of an exfoliation reagent ([Figure 2B](#F0002){ref-type="fig"}).[@CIT0029] Indeed, this reductive method was more facile in both principle and practice because a variety of reductants could be selected. Furthermore, the synthetic process for the MnO~2~ NSs was more controllable. Nonetheless, an inevitable drawback was that KMnO~4~ tended to decompose in hydrothermal environments (*ca*. 95°C), which challenged researchers attempting to verify the exact mechanisms of the corresponding chemical reactions.[@CIT0030]--[@CIT0034] Figure 2(**A**) Schematic illustration for the control experiments of reductants employed in the growth of MnO~2~ nanomaterials at ambient temperature (left) and TEM characterization of the corresponding products (right). Reprinted with permission from Deng R, Xie X, Vendrell M, Chang Y, Liu X. Intracellular glutathione detection using MnO(2)-nanosheet-modified upconversion nanoparticles. *J Am Chem Soc*. 2011;133(50):20168--20171.[@CIT0028] Copyright 2011 American Chemical Society. (**B**) Schematic illustration for MnO~2~ NS formation based on the KMnO~4~ and SDS reaction. Reprinted with permission fromLiu Z, Xu K, Sun H, Yin S. One-step synthesis of single-layer MnO2 nanosheets with multi-role sodium dodecyl sulfate for highperformance pseudocapacitors. *Small*. 2015;11(18):2182--2191.[@CIT0029] Copyright © 2015, John Wiley and Sons.

Biomedical applications of MnO~2~ nanosheets (MnO~2~ NSs) {#S0003}
=========================================================

Since the intriguing 2D structure and distinct physical/chemical properties were initially identified, MnO~2~ NSs have received much attention and have exhibited favorable potential for application in a wide range of disciplines, such as physics,[@CIT0037] chemistry,[@CIT0038] material science[@CIT0039] (especially energy-related applications, eg, solar cells,[@CIT0040] supercapacitors,[@CIT0041]--[@CIT0045] and lithium-ion batteries[@CIT0046],[@CIT0047]), optoelectronics,[@CIT0048],[@CIT0049] spintronics,[@CIT0018] biomedicine,[@CIT0040] and so forth. Particularly, their broad use in biological sensing and catalysis, drug delivery and controlled release, PTT and chemo-dynamic therapy (CDT),[@CIT0021] molecular imaging and engineering, etc., has shown promising potential. Herein, we summarize a majority of the MnO~2~ NS applications in recent years in the field of biomedicine ([Figure 3](#F0003){ref-type="fig"}). Figure 3Schematic illustration of the diverse roles MnO~2~ NSs have played in the field of biomedicine.

As a nanozyme: biocatalysis based on MnO~2~ NSs {#S0003-S2001}
-----------------------------------------------

In recent decades, nanotechnology and biochemistry have flourished, including artificial materials with multiple applications.[@CIT0007],[@CIT0050],[@CIT0051] Certain nanomaterials possess enzymatic-like profiles and substrate specificities, which are commonly called "Nanozymes". Despite the substrate specificities of nanozymes rarely being as high as those of natural enzymes, their multiple active sites favor more efficient and steady catalytic activity. Additionally, owing to their tunable structures, their related properties can be controlled and optimized.[@CIT0052],[@CIT0053] Furthermore, compared with natural enzymes, nanozymes are more compatible with specific environments, such as high temperatures, and low or high pH conditions.[@CIT0054] These features give rise to their promising applications in a variety of fields.

Nanozymes, mainly comprising carbon,[@CIT0055],[@CIT0056] metal,[@CIT0057],[@CIT0058] and metal oxide,[@CIT0059],[@CIT0060] mimic the functionality of natural enzymes, but have different structures. Amongst them, 2D nanomaterials,[@CIT0061] with ultralarge surface areas and flexible structures, enable their excellent catalytic activity and can be incorporated into the surrounding environment to improve substrate specificity. For instance, graphene oxide has been confirmed to possess intrinsic peroxidase-like activity in the presence of hydrogen peroxide (H~2~O~2~),[@CIT0062],[@CIT0063] so as to ultrathin graphitic carbon nitride (g-CN)[@CIT0064],[@CIT0065] and molybdenum disulfate nanosheets (MoS~2~ NSs),[@CIT0066] which are only pragmatic for use as *ex-vivo* or in vitro substrates. MnO~2~ NSs, a typical 2D nanomaterial, also possess intrinsic oxidase-like activity. In 2012, Liu and Wang et al. employed 3,3ʹ,5,5ʹ-tetramethylbenzidine (TMB) as a tracer to test this property.[@CIT0067] The oxidation of the pale yellow-colored substrate (TMB) to the blue-oxidized product (ox-TMB) indicated the catalytic activity of the MnO~2~ NSs. Based on this, Liu and colleagues have developed a selective, rapid, and reliable colorimetric assay for the determination of GSH because GSH can further lead to a concentration-dependent reduction of ox-TMB and a proportional decrease in the absorption at ca. 650 nm ([Figure 4A](#F0004){ref-type="fig"}).[@CIT0068] Notwithstanding their utilization as a group of nanozymes with oxidase activity, MnO~2~ NSs can also act as indirect DNA partzymes to some extent. Recently, Zhao et al fabricated a MnO~2~ NS-powered target/probe Janus protected DNA nanomachine to achieve RNA imaging. In this DNA machine, the MnO~2~ NSs were utilized as both promoters for the cellular uptake of DNA and generators of Mn^2+^ as indispensable DNAzyme cofactors, ensuring the efficiency of catalytic cleavage ([Figure 4B](#F0004){ref-type="fig"}).[@CIT0069] Figure 4(**A**) Illustration of the MnO~2~ NS-based colorimetric assay for GSH quantification, where the MnO~2~ NSs acted as an oxidase-like nanozyme for the formation of ox-TMB and GSSG. Reprinted from Biosensors and Bioelectronics, 90, Liu J, Meng L, Fei Z, Dyson P, Jing X, Liu X. MnO nanosheets as an artificial enzyme to mimic oxidase for rapid and sensitive detection of glutathione, 69--74, Copyright (2017), with permission from Elsevier.[@CIT0068] (**B**) Schematic design of the Janus protected DNA nanomachine, where miRNA-21 is employed as a model cellular RNA target (green sequence), the red X denotes DNA, PS (phosphorothioate)-DNA, 2ʹOMe (methylation)-DNA and LNA (locked nuclease acid) monomers, which are highlighted in the DNA partzymes (gray sequences). Reprinted with permission from Chen F, Bai M, Zhao Y, Cao K, Cao X, Zhao Y. MnO-nanosheet-powered protective janus DNA nanomachines supporting robust RNA imaging. *Anal Chem*. 2018;90(3):2271--2276.[@CIT0069] Copyright 2018 American Chemical Society.

As a quencher: fluorescence sensing based on MnO~2~ NSs {#S0003-S2002}
-------------------------------------------------------

The use of 2D nanomaterials with light harvesting and/or electron-conducting capacities has emerged as a promising nanoplatform for biological and/or chemical sensing based on the fluorescence resonance energy transfer (FRET), photoinduced transfer mechanisms, etc.[@CIT0070],[@CIT0071] Fluorescence or Förster resonance energy transfer (FRET) is a mechanism delineating nonradiative energy transfer[@CIT0072] from a luminescent donor to an energy acceptor in proximity (ie, 1--10 nm) mediated by dipole-dipole coupling.[@CIT0073],[@CIT0074] Due to its high sensitivity and suitability for homogeneous detection, FRET has been universally utilized in a variety of fields, eg, microscope,[@CIT0075] immunoassay,[@CIT0076],[@CIT0077] nucleic acid hybridization[@CIT0078]--[@CIT0081] and macromolecule interactions .[@CIT0082],[@CIT0083] As a 2D nanomaterial as well as an ultrathin semiconductor, MnO~2~ NSs exhibit a broad and intense absorption band at ca. 374 nm,[@CIT0024] making them as an efficient broad-spectrum quencher, which is resulted from the d--d transitions of manganese ions in the ligand field of the edge-sharing MnO~6~ octahedral crystal lattice.[@CIT0024] The use of MnO~2~ NSs as fluorescence quencher can mainly be ascribed to two aspects: their broad and intense absorption band at ca. 374 nm and the break-up of the NSs structure with the reduction of MnO~2~ into Mn^2+^. Ji et al designed a multifunctional nanosystem, CaO~2~/MnO~2~\@polydopamine-methylene blue (MB) nanosheets (CMP-MB), where the fluorescence of MB was suppressed by the MnO~2~ NS. Once exposed to a tumor microenvironment, the MnO~2~ NSs could decompose into Mn^2+^, which triggered the emission of MB fluorescence. Hence, switch-controlled tumor cell imaging was achieved.[@CIT0084] Xia et al. found that the MnO~2~ NS mediated quenching effect can be reversed via the reduction of MnO~2~ into Mn^2+^ by ascorbic acid (AA), resulting in MnO~2~ NS destruction. Based on this, they developed a carbon dot (CD)-MnO~2~ nanocomposite for the determination of ALP with help from the hydrolysis of 2-phosphate (AAP) into AA. Utilizing the CD-MnO~2~ nanocomposite as a sensing probe, a label-free fluorescent switching strategy for detecting ALP activity was realized with a limit of detection (LOD) of 0.4 U/L.[@CIT0085] In 2015, with the reduction of MnO~2~ into Mn^2+^ by GSH, Wang and coworkers employed fluorescent CDs and MnO~2~ NSs as an energy donor-acceptor pair to construct a nanoplatform for GSH detection ([Figure 5A](#F0005){ref-type="fig"}).[@CIT0086] In addition to employing MB and CDs as fluorescence donors, Yan et al fabricated a graphene quantum dot (GQD)-MnO~2~ NS-based optical sensing platform for GSH detection ([Figure 5B](#F0005){ref-type="fig"}).[@CIT0087] Chu and colleagues developed a MnO~2~ NS-modified upconversion (UC) nanosystem for sensitive switchable fluorescence detection of H~2~O~2~ and glucose in blood. The enzymatic cleavage and unification of glucose by glucose oxidase (GOx) generated H~2~O~2~, which was then utilized to reduce MnO~2~ to Mn^2+^, similarly to GSH (as depicted by the equation: MnO~2~+ H~2~O~2~+2H^+^ = Mn^2+^ +2H~2~O + O~2~) ([Figure 5C](#F0005){ref-type="fig"}).[@CIT0088] Figure 5(**A**) Schematic illustration of the preparation of CDs-MnO~2~ NSs and the principle of the FRET-based CD-MnO~2~ NSs architecture for GSH sensing. Republished with permission of Royal Society of Chemistry, from A sensitive turn-on fluorescent probe for intracellular imaging of glutathione using single-layer MnO2 nanosheet-quenched fluorescent carbon quantum dots, He D, Yang X, He X, et al, 51, 79, 2015; permission conveyed through Copyright Clearence Centre, Inc.[@CIT0170] (**B**) Scheme for the preparation of MnO~2~ NSs and the mechanism of a GQD-MnO~2~ NS-based optical sensing nanoplatform for monitoring GSH in MCF-7 cells. Reprinted with permission from Yan X, Song Y, Zhu C, et al. Graphene quantum dot-MnO2 nanosheet based optical sensing platform: a sensitive fluorescence"Turn Off-On" nanosensor for glutathione detection and intracellular imaging. *ACS Appl Mater Interfaces*. 2016;8(34):21990--21996.[@CIT0087] Copyright 2016 American Chemical Society. (**C**) Schematic illustration of a g-C~3~N~4~ NS-MnO~2~ NS sandwich-like nanocomposite for GSH sensing. Reprinted with permission from Zhang X, Zheng C, Guo S, Li J, Yang H, Chen G. Turn-on fluorescence sensor for intracellular imaging of glutathione using g-C3N4 nanosheet-MnO2 sandwich nanocomposite. *Anal Chem*. 2014;86(7):3426--3434.[@CIT0151] Copyright 2014 American Chemical Society.

In addition to sensing relatively more tractable and visible substances, such as GSH and H~2~O~2~,MnO~2~ NSs can also be utilized for tracking RNAs even at very low levels. As is well-known, miRNAs can regulate gene expression by promoting the degradation or inhibition of the translation of target messenger RNAs (mRNAs) in epigenetics,[@CIT0089]--[@CIT0091] thereby playing momentous roles in cell differentiation,[@CIT0092]--[@CIT0095] proliferation,[@CIT0096] tumorigenesis,[@CIT0097],[@CIT0098] metastasis,[@CIT0099],[@CIT0100] apoptosis,[@CIT0098] autophagy[@CIT0101],[@CIT0102] and many other biochemical processes. Despite quantitative determination of various miRNAs being accomplished by traditional detection strategies, eg, PCR and northern blot, these previously developed methods possess unavoidable costs and are time-consuming as well as having sensitivity limiting shortcomings. Therefore, recent alternatives have incorporated a variety of signal amplification approaches such as nanomaterials,[@CIT0080],[@CIT0103]--[@CIT0106] enzymes,[@CIT0107] electrochemical[@CIT0108] or electrochemiluminescent[@CIT0109] transduction fashion to detect target miRNAs with both high selectivity and high sensitivity. In 2017, Xiang and colleagues reported a biodegradable MnO~2~ NS-based hybridization chain reaction (HCR) strategy to determine miRNA expression even at exceedingly low levels in living cells.[@CIT0110] They designed two hairpins which were separately labeled with the organic dyes FAM (as a FRET donor) and Tamra (TMR, as a FRET acceptor) and loaded onto MnO~2~ NSs. Thereafter, once entering living cells, the hairpins would be released because of the displacement responses as well as the degradation of the MnO~2~ NSs by intracellular GSH. Then, miRNA-21 in living HeLa cells triggered the hairpins to convene into double-stranded polymers, resulting in prominent amplification of the FRET signal for the determination of trace levels of miRNA-21 in living cells ([Figure 6](#F0006){ref-type="fig"}).[@CIT0111] It is anticipated that this inspiring work might open up new opportunities for monitoring multiple trace-level RNA species in living cells with greater accuracy, sensitivity and integrity. Figure 6Schematic illustration of the MnO~2~ NS-mediated intracellular-hybridized chain reaction (HCR) signal amplification system for efficiently detecting miRNA-21 in living HeLa cells. The MnO~2~ NSs could deliver two types of hairpin DNA probes into the cytosol. Overexpressed glutathione (GSH) in HeLa cells and displacement reactions by other proteins or nucleic acids promoted the decomposition of the MnO~2~ NSs to release free hairpins, which assembled into double-stranded (dsDNA) polymers upon binding to the target miRNA-21. Subsequently, enhanced FRET signals were produced to realize accurate and sensitive detection. Reprinted with permission from Li J, Li D, Yuan R, Xiang Y. Biodegradable MnO2 nanosheet-mediated signal amplification in living cells enables sensitive detection of down-regulated intracellular MicroRNA. *ACS Appl Mater Interfaces*. 2017;9(7):5717--5724.[@CIT0111] Copyright 2017 American Chemical Society.

Finally, the applications of various MnO~2~ NS-based fluorescent biosensors for determining specific targets are listed in [Table 2](#T0002){ref-type="table"}, and their different values for the limits of detection (LODs) as well as the linear concentration ranges of the corresponding targets are mentioned. Table 2Fluorescent biosensors based on MnO~2~ NSsNanomaterialsTargetsLinear response concentrationLimit of detection (LOD)ReferenceCDs-MnO~2~NS architectureGSH0.2--600 µM22 nM[@CIT0086]CDs-MnO~2~ nanocompositeALP1--100 U/L0.4 U/L[@CIT0085]CQDs-MnO~2~ nanocompositeGSH0.01--200 µM0.01 µM[@CIT0170]GQDs-MnO~2~ nanoplatformGSH0.5--10 µM150 nM[@CIT0087]g-C~3~N~4~-MnO~2~nanosandwichGSH200--500 µMN/A[@CIT0151]MnO~2~ NS-UCP nanosystemGSH and H~2~O~2~0--250 and 250--400 µM3.7 µM[@CIT0088]MnO~2~ NS-UCP nanosystemL-lactic acid50--400 and 450--800 µM10 µM[@CIT0088]MnO~2~ NS-FAM +TMR hairpinsmiRNA-21100--250 nM100 nM[@CIT0111]MnO~2~ NS label-free platformMercury(II) (Hg^2+^)0--20 n M0.8 nM[@CIT0112]MnO~2~ NS label-free platformOchratoxin (OTA)0.02--2 nM0.02 ng/mL[@CIT0113]MnO~2~ NS label-free platformCathepsin (Cat D)1--100 ng/mLN/A[@CIT0113]MnO~2~ NS-7-hydroxycoumarinAscorbic acid0.5--40 µM0.09 µM[@CIT0114]MnO~2~ NS-7-hydroxycoumarinGSH1--25 µM300 nM[@CIT0068]MnO~2~ NS & ligand-DNA FPSilver ions (Ag^+^)30--240 nM9.1 nM[@CIT0115]Ru(BPY)~3~\@MnO~2~ nanoprobeGSH0--300 µM420 nM[@CIT0157]MSNs-G\@MnO~2~ NSsGSH100 nM to 10 µM34 nM[@CIT0116]MnO~2~ NS-cascade logic circuitGSH20--2,000 nM6.7 nM[@CIT0152][^3]

As a nanocarrier for controlled drug delivery: cargo-loading functionality based on MnO~2~ NSs {#S0003-S2003}
----------------------------------------------------------------------------------------------

As mentioned above, MnO~2~ NSs, with extremely large SMRs, exhibit a wide range of distinctive physicochemical properties compared with their bulk composition. One of most typical biomedical applications of MnO~2~ NS, is drug delivery due to their large SMRs. Moreover, distinct from conventional drug delivery systems (DDSs), MnO~2~ NS-based nanoplatforms can function as controlled or on-demand DDSs. The controlled drug delivery systems (c-DDSs) for current medications have received increasing interest from numerous chemists and clinical physicians owing to their low toxicities, broad therapeutic windows and ideal administrational efficacies compared with conventional DDSs.[@CIT0117]--[@CIT0121] On-demand DDSs triggered by intrinsic physiological microenvironment changes (eg, pH,[@CIT0122] redox agents,[@CIT0123],[@CIT0124] enzymes,[@CIT0125] and heat[@CIT0126],[@CIT0127]) and/or external artificially introduced stimuli[@CIT0128],[@CIT0129] (eg, light,[@CIT0130] laser pulses,[@CIT0131] magnetic/electronic fields,[@CIT0132] and ultrasonication[@CIT0133]) can simultaneously diminish the side-effects of anticancer agents toward normal tissue to improve the therapeutic effects. Previous reports on DDSs have mainly focused on nanocomposites, such as magnetic composites and upconversion nanoparticles, and most of them have been magnetically functionalized mesoporous materials or hollow spherical particles with the drugs being released via changes in the pH or temperature.[@CIT0121],[@CIT0134]--[@CIT0137] For the use of MnO~2~ NSs as controlled drug delivery nanocarriers, two main properties are beneficial: a large specific surface area and a sensitive response to the tumor microenvironment. In 2013, Zhao et al proposed a novel and facile strategy for the fabrication of multifunctional nanocomposites with silica-coated Fe~2~O~3~ particle cores and NaYF4׃Yb,Er shells, on which MnO~2~ NSs were further grown for delivery and release of a model drug, Congo red (CR). In this nanosystem, the MnO~2~ NSs served not only as carriers for the loading and release of CR*in vitro* but also as efficient quenchers for the UC luminescence to monitor intracellular GSH concentration ([Figure 7](#F0007){ref-type="fig"}).[@CIT0138] The drug was released upon reduction of MnO~2~ to Mn^2+^ by GSH, while simultaneously increasing the UC luminescence. The fabricated nanocomposite is a promising platform due to its GSH-stimulated smart drug delivery and UC luminescence monitoring. Indeed, the nanocarrier functionality of MnO~2~ NSs has rarely been applied individually and has always been combined with other pragmatic components, eg, fluorescence quenchers and magnetic resonance imaging (MRI) probes, which will be mentioned below. Figure 7(A) Schematic illustration of the synthetic procedure for the preparation of the MSU/MnO~2~-CR drug delivery system. (**B**) Images of the MSU/MnO~2~-CR system before and after drug delivery under 980 nm excitation. Republished with permission of Royal Society of Chemistry, from Multifunctional MnO2 nanosheet-modified Fe3O4\@SiO2/NaYF4: yb,Er nanocomposites as novel drug carriers, Zhao P, Zhu Y, Yang X, et al, 43, 2, 2014; permission conveyed through Copyright Clearence Centre, Inc.[@CIT0138]

As an MRI pro-contrast agent: stimuli-activated imaging based on MnO~2~ NSs {#S0003-S2004}
---------------------------------------------------------------------------

MRI was originally known as nuclear magnetic resonance (NMR)[@CIT0139] imaging and belongs to a configuration of NMR, albeit the "nuclear" employed in the acronym was omitted to avoid negative associations with the word. Certain atomic nuclei are capable of absorbing and releasing radiofrequency (RF) energy in the presence of an external magnetic field. Hydrogen atoms are typically applied to boost the detectable RF signals which can be received by antennas in proximity to the corresponding anatomy for examination. By altering the parameters of the pulse sequence, different degrees of contrast may be generated between tissues based on the relaxation properties of their hydrogen atoms.[@CIT0140],[@CIT0141] Compared with other imaging modalities, the main advantage of MRI is its superb spatial resolution whereas its major drawback is the limited sensitivity. As such, chemistry and materials science research has focused on searching for solutions capable of solving this challenging hurdle[@CIT0142] The introduction of contrast agents (CAs) has been the main solution. Paramagnetic complexes comprising metal ions with symmetric electronic ground states, eg, gadolinium (Gd^3+^)[@CIT0143] and manganese (Mn^2+^),[@CIT0144] have been successfully applied as MRI CAs since the late 1980s[@CIT0145] in virtue of their outstanding capabilities to decrease the longitudinal relaxation time T~1~ of water protons dipolarly interacting with the unpaired electrons of the metal ions. Manganese-based oxides have been demonstrated as alternative CAs for T~1~-weighted MRI, with relatively improved biocompatibilities and cytotoxicities, to replace the clinically widespread gadolinium-based CAs, which have been warned by US Food and Drug Administration (FDA) due to the correlation between gadolinium and nephrogenic systemic fibrosis, kidney dysfunction, etc.[@CIT0146]--[@CIT0149] The Mn atoms in MnO~2~ nanosheets are coordinated in an octahedral geometry to six oxygen atoms and shielded from aqueous environments, making no contribution to the longitudinal or tranverse relaxation of the protons.[@CIT0150] As Zhang and coworkers reported, the relaxation rate (r~1~ value) of initial PEG-MnO~2~ NSs was very low (0.007 mM−[@CIT0001] s−[@CIT0001]), which was ascribed to the high valence (IV) of manganese and the shielded paramagnetic centers being inaccessible to water molecules.[@CIT0151] Upon disintegration and degradation, the released Mn^2+^ gives rise to a highly improved T~1~-MRI performance because of the five unpaired 3d electrons and the enhanced accessibility of the paramagnetic centers to the surrounding water molecules. As illustrated by Zhang et al, the longitudinal relaxivity r~1~ and transverse relaxivity r~2~, obtained by measuring the relaxation rate as a function of Mn concentration, exhibited a 48- (from 0.1 to 4.89 mM^−1^ s^−1^) and 120-fold (from 0.42 to 50.57 mM^−1^ s^−1^) enhancement, respectively, when the MnO~2~ NSs were reduced to Mn^2+^ by GSH ([Figure 8A](#F0008){ref-type="fig"}).[@CIT0150] The decomposition of MnO~2~ NSs in the tumor microenvironment (GSH-activated[@CIT0152],[@CIT0153] or pH-dependent[@CIT0154],[@CIT0155]) to release Mn^2+^ can be utilized for tumor cell MR imaging. Wang and Shi's group in 2014, presented an intriguing achievement with their report on an intelligent theranostic platform based on highly disperse 2D MnO~2~ NSs for concurrent ultrasensitive pH-responsive MRI and drug delivery/release.[@CIT0156]Figure 8(**A**) Determination of the T~1~ (left) and T~2~ (right) relaxation rates of a MnO~2~ nanosheet solution (red lines) and MnO~2~ nanosheet solution treated with GSH (black lines). The related T~1~-weighted and T~2~-weighted MRI images were presented below. (**B**) Schematic illustration of the activation mechanism of the MnO~2~ NS-aptamer nanoprobe for fluorescence/MRI bimodal tumor cell imaging. Reprinted with permission from Zhao Z, Fan H, Zhou G, et al. Activatable fluorescence/MRI bimodal platform for tumor cell imaging via MnO2 nanosheet-aptamer nanoprobe. *J Am Chem Soc*. 2014;136(32):11220--11223.[@CIT0150] Copyright 2014 American Chemical Society.

In addition to MRI, MnO~2~ NSs have shown promising potential for the fabrication of dual-activatable fluorescence/MRI bimodal platforms. In 2014, Tan and coworkers designed a redox-capable MnO~2~ NS-aptamer nanoprobe for multimodal imaging of tumor cells ([Figure 8B](#F0008){ref-type="fig"}).[@CIT0150] In this platform, the MnO~2~ NSs played three roles as a DNA nanocarrier, fluorescence quencher and intracellular GSH-activated MRI CA. Upon encountering the target cells, the binding of the aptamer to the corresponding target weakened the absorption of the probe on the NSs and produced a fluorescence recovery as well as aptamer-mediated endocytosis. The intracellular GSH further reduced the MnO~2~ NSs into a large amount of Mn^2+^ suitable for MRI. Using a similar principle, a MnO~2~ NS-Ru(II) complex nanoarchitecture, Ru(BYP)~3~\@MnO~2~ (BYP = 2,2ʹ-bipyridine) has also been developed for determining GSH in vitro and in vivo.[@CIT0157]

Despite the multimodal imaging applications of MnO~2~ NSs in conjunction with their fluorescence and MR imaging, many exploits have been attempted to accomplish theranostic applications (ie, imaging and killing at the same time). Notably, the PEG-MnO~2~ NSs reported by Wang and colleagues in 2014 promoted ultrasensitive pH-triggered concurrent diagnostic and therapeutic functionalities (designated as theranostics) for cancers, which provided a novel and facile platform for concurrent ultrasensitive pH-stimulated T~1~-weighted MRI and anti-tumor drug (doxorubicin, Dox) release ([Figure 9](#F0009){ref-type="fig"}).[@CIT0156] The pH-triggered rapid decomposition of 2D MnO~2~ NSs in a mildly acidic microenvironment could facilitate the controlled release of delivered anticancer agents and circumvent the multidrug resistance of cancer cells by bypassing the typical P-glycoprotein (P-gP)-induced efflux process with MnO~2~ NSs due to their larger size than free Dox molecules.[@CIT0158] Figure 9(**A**) Schematic illustration of the synthetic procedure for the PEG-MnO~2~ NSs. (**B**) Theranostic functionality of the PEG-MnO~2~ NSs for intracellular pH-responsive drug release and the axial and coronal T~1~-MRI images of 4T1 tumor-bearing nude mice before (a~1~, b~1~) and after (a~2~ -- a~9~ and b~2~ -- b~9~) administration of the PEG--MnO~2~ nanosheets within the tumor and normal subcutaneous tissue. PEG denotes ethylene glycol. Reproduced with permission from Chen Y, Ye D, Wu M, et al. Break-up of two-dimensional MnO2 nanosheets promotes ultrasensitive pH-triggered theranostics of cancer. *Adv Mater Weinheim.* 2014;26(41):7019--7026.[@CIT0156] Copyright © 2014, John Wiley and Sons.

MnO~2~ NSs themselves can be used not only as nanocarriers for drug delivery, but also as therapy agents. Recently, Xiaoyuan Chen and colleagues at the National Institute of Health (NIH) reported that the construction of MnO~2~-based nanoagents can augment the efficiency of CDT ([Figure 10](#F0010){ref-type="fig"}).[@CIT0021] CDT utilizes iron-initiated Fenton chemistry to kill tumor cells via the conversion of endogenous H~2~O~2~ into hydroxyl radicals (·OH), which have a high toxicity, inducing intracellular oxidative stress.[@CIT0159]--[@CIT0162] To date, a number of iron-carrying nanoparticles have been employed as CDT agents to induce ferroptosis[@CIT0163] in tumor cells via H~2~O~2~-dependent Fenton-like reaction.[@CIT0164]--[@CIT0167] As envisaged, the overproduction of GSH in tumor cells ought to be one of the most formidable hurdles for the CDT effect in that GSH serves as a scavenger of the highly reactive ·OH generated by chemodynamic agents, thereby increasing the resistance of cancer cells to oxidative stress and diminishing the efficacy of CDT.[@CIT0168],[@CIT0169] Chen et al was the first time to report that MnO~2~, which possesses both Fenton-like Mn^2+^ delivery and GSH depletion capabilities, could play a role as a novel chemodynamic agent in order to improve the CDT of cancer via simultaneously disrupting the antioxidant system and loading an ·OH generator into cells. Ultimately, they utilized MnO~2~ NSs to successfully construct an activatable theranostic nanosystem for an MRI-monitored chemo-chemodynamic combination regimen.[@CIT0021]Figure 10Schematic illustrations of the mechanism and application of mesoporous silicon (MS)\@MnO~2~ NPs for MRI-monitored chemo-chemodynamic combination therapy. Reproduced with permission from Lin L, Song J, Song L, et al. Simultaneous fenton-like ion delivery and glutathione depletion by MnO-based nanoagent to enhance chemodynamic therapy. *Angew Chem Int Ed Engl*. 2018;57(18):4902--4906.[@CIT0021] Copyright © 2018, John Wiley and Sons.

In conclusion, as an MRI CA, MnO~2~ NSs can produce an activatable MRI signal upon the degradation of their structure in the tumor microenvironment, favoring the improvement of the signal-to-noise ratio and specificity. Additionally, benefitting from the high surface area, fluorescence quenching ability and CDT ability of MnO~2~ NSs, MRI-based theranostic platforms and multimodal imaging nanoprobes can be easily fabricated with the help of MnO~2~ NSs, which undoubtedly broadens the applications of MRI.

Taken together, MnO~2~ NSs have displayed promising potential in multiple modalities for the diagnosis, treatment and theranostics of tumors in vitro and in vivo.

Toxicity evaluation of MnO~2~ nanosheets (MnO~2~ NSs) {#S0004}
=====================================================

With the widespread use of MnO~2~ NSs in a range of biomedical applications, their toxicological assessment both in vitro and in vivo is extremely important. Nonetheless, there are still a limited number of toxicity studies on MnO~2~ NSs especially in vivo. MTT assays and cell counting kit-8 (CCK-8) assays are two commonly employed methods to assess the toxicity of MnO~2~ NSs in various cells. Herein, we present the main cytotoxicity testing results of various nanomaterials based on MnO~2~ NSs. He et al developed a single-layer MnO~2~ NS-quenched fluorescent carbon quantum dots, and their nanosystem exhibited no apparent cytotoxicity at the concentrations of 30 µg/mL or less when exposed to HeLa human cervical carcinoma cells for 24 hrs.[@CIT0170] Similarly Yan et al reported of GQD-MnO~2~ NS based optical sensing nanoplatform and confirmed that this nanomaterial had low toxicity even at a concentration of 40 µg/mL, toward MCF-7 breast adenocarcinoma cells.[@CIT0087] Zhang et al have reported that their graphitic-C~3~N~4~NS-MnO~2~ sandwich-like nanocomposite displayed no apparent loss in cell viability even at a 50 µg/mL exposure to HeLa cells.[@CIT0151] Recently, corresponding cytotoxicological assessments of MnO~2~ NS-based nanosystems in HeLa and MCF-7 cells were carried out by the Xiang group,[@CIT0111] Chen and coworkers[@CIT0069] and Shi and colleagues.[@CIT0157] They all reported excellent biocompatibilities and insignificant viability losses as listed in [Table 3](#T0003){ref-type="table"}. It is also remarkable that the effort of Zhao et al to fabricate MnO~2~ NS-aptamer nanoprobes early in 2014 verified that 79% of CCRF-CEM and Ramos human B lymphoma cells remained alive following by exposure to their nanoprobes at a concentration of 1 mM for 24 hrs.[@CIT0150] Table 3Cytotoxicity results of various nanomaterials based on MnO~2~ NSsNanomaterialsCell linesResponse, maximum exposure concentration, and durationTesting assaysReferenceCQDs-MnO~2~ NSHeLaNo apparent loss of cell viability, 30 µg/mL, 24 hrsMTT[@CIT0170]GQDs-MnO~2~ nanoprobeMCF-7Low cytotoxicity, 40 µg/mL, 24 hrsMTT[@CIT0087]g-C~3~N~4~-MnO~2~ nanosandwichHeLaNo apparent loss of cell viability, 50 µg/mL, 24 hrsCCK-8[@CIT0151]MnO~2~ NS-FAM + TMR hairpinsHeLaInsignificant viability loss, 86% alive, 60 µg/mL, 24 hrsMTT[@CIT0111]MnO~2~ NS-FAM + TMR hairpinsMCF-7 & HepG2Low cytotoxicity, 90 µg/mL, 24 hrsMTT[@CIT0171]MnO~2~ NS-Janus DNA machineMCF-7Good biocompatibilty, 100 µg/mL, 24 hrsMTT[@CIT0069]MnO~2~ NS-aptamer nanoprobeCCRF-CEM and Ramos79% of cells remained alive, 1 mM, 24 hrsMTS[@CIT0150]Ru(BPY)~3~\@MnO~2~ nanoprobeHeLaThe viabilities remained higher than 87%, 160 µM, 24 hrsMTT[@CIT0157]MnO~2~ NS-"DD-A" binary probeHepG2Low cytotxicity, 90 µg/mL, 24 hrsMTT[@CIT0172][^4]

Conclusion and perspectives {#S0005}
===========================

Over the last few decades, research on the synthesis and biomedical applications of MnO~2~ NSs has thrived and seen impressive advancements. In this review, first of all, we highlighted the state-of-the-art strategies that have been developed for the preparation of MnO~2~ NSs by top-down or bottom-up methods. Notwithstanding, in contrast to other 2D nanomaterials, the top-down approach of MnO~2~ NS synthesis is obviously costly and time-consuming. Moreover, it is fairly difficult to completely exfoliate the protonated compounds completely into single-layer NSs (monosheets), thus, previously obtained NSs have always had a wide thickness distribution in practice. The bottom-up strategies, comprising the oxidative and the reductive methods, have been widely utilized widespread. MnO~2~ NSs can be facilely prepared via the reduction of KMnO~4~ in the presence of an MES buffer at pH 6 or through the oxidation of MnCl~2~ with oxidants, eg, H~2~O~2~ in the coexistence of TMA·OH as summarized above. Numerous reductants can be selected, and the synthetic process for MnO~2~ NSs is tunable. Although many intriguing methods have been developed in this inspiring research field, it is still urgent to develop new facile and effective methods for the synthesis of high-quality MnO~2~ NSs.

Then, we provided an overview of the main applications of MnO~2~ NSs in biomedicine. MnO~2~ NSs can play multiple roles as nanozymes, nanocargos, fluorescence quenchers and activatable MRI probes. Hitherto, almost all of the reported biomedical applications have been based on these four fundamental functionalities and their roles are not dichotomies towards each other. Numerous researchers have focused on integrating MnO~2~ NSs into multiple modalities to explore increasingly novel uses in biomedicine.

Last but not the least, biosafety is one of the most concerning issues for the use of nanomaterials in biomedical employments before end-point clinical translation, despite the knowledge of the toxicity for MnO~2~ NSs are still very preliminary and limited. Therefore, the toxicity of MnO~2~ NSs should be systematically and comprehensively validated, especially in vivo. In addition, several intermediate metabolites accumulate in living organisms and cannot be easily degraded or detoxified, resulting in long-term toxicity issues, which should be further considered.

In the future, for MnO~2~ NS-related research, the biosafety should be considered first. Thus, green synthetic approaches are preferred for obtaining MnO~2~ NSs with controllable thicknesses, sizes and morphologies. The biomedical applications of MnO~2~ NSs have experienced markedly rapid advancement over the last few decades. However, the targets are relatively limited. Extra attention should be paid to integrating proper targeting aptamers/antigens/antibodies especially those that play important roles in cancer cell signaling pathways with MnO~2~ NSs. This will help to improve both the performance of biosensors and the efficacy of cancer theranostics based on MnO~2~ NSs. Furthermore, additional applications of MnO~2~ NSs such as PTT and imaging-guided combination therapy, should be considered to broaden their biomedical applications. As envisaged optimistically, the MnO~2~ NSs will provide promising opportunities for the realization of more advanced medical imaging. We also believe that this review may entice other scientists in multiple disciplines to join into this new but growing research field.
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